Spruce Biosciences Inc
NASDAQ:SPRB 4:00:00 PM EDT
| Market Cap (Intraday) | 28.84M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.76 |
| 50-Day MA | $2.88 |
| 200-Day MA | $2.27 |
Spruce Biosciences Inc Stock, NASDAQ:SPRB
611 Gateway Boulevard, Suite 740, South San Francisco, California 94080
United States of America
Phone: +1.415.655.4168
Number of Employees: 29
Description
Spruce Biosciences, Inc. is a late-stage biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. It focuses on developing its wholly owned product candidate, Tildacerfont. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.